Previous 10 | Next 10 |
home / stock / cvalf / cvalf news
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023. Brent Ashton, Covalon’s newly appointed Chief Executive Officer stat...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where sharehold...
2024-01-26 08:34:47 ET More on Covalon Technologies Financial information for Covalon Technologies Read the full article on Seeking Alpha For further details see: Covalon Technologies GAAP EPS of -C$0.12, revenue of C$6.89M
2024-01-26 07:54:01 ET More on Covalon Technologies Financial information for Covalon Technologies Read the full article on Seeking Alpha For further details see: Covalon names Katie Martinovich as Interim Chief Financial Officer
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the following management changes. Interim CFO Appointment and Transition The Company will appoint Ms. Katie Martinovich as Interim Chief Financia...
Reports 2023-Q4 revenue of $6.9 million – an increase of 28%, net loss from continuing operations of $2.9 million – an improvement of $1.2 million Reports full year 2023 revenue of $26.6 million – an increase of 47%, net loss from continuing operations of $4.5 million ...
2024-01-04 07:55:12 ET More on Covalon Technologies Financial information for Covalon Technologies For further details see: Covalon Technologies appoints Brent Ashton as CEO
Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) (the " Company " or " Covalon "), an advanced medical technologies company, today announced that its Board of Directors (the “ Board ”) has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director o...
BJN publication featuring VALGuard offers healthcare professionals essential Continuing Education Credits Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today proudly announced the publication of an article in ...
2023-10-20 08:31:49 ET More on Covalon Technologies Covalon Technologies Ltd. 2023 Q3 - Results - Earnings Call Presentation Financial information for Covalon Technologies For further details see: Covalon announces issuance of deferred share units
News, Short Squeeze, Breakout and More Instantly...
Recent changes and effective execution pave the way for strong Q2 results Q2 EBITDA of $1.7 million, Adjusted EBITDA of $2.5 million, and EPS of $0.06 Q2 year-on-year Revenue growth of 16%, focus area of US Product segment grew 54% Q2 Gross Margin increased to 63%, the h...
Faraday Future Intelligent Electric Inc. (FFIE) is expected to report for Q1 2024 D-Market Electronic Services & Trading (HEPS) is expected to report for Q1 2024 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2024 Check-Cap Ltd. (CHEK) is expected to report $-0.17 for ...
Covalon Technologies Ltd. (CVALF) is expected to report for Q2 2024